- Home
- INUV vs LPCN Comparison
INUV vs LPCN Comparison
Compare INUV & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INUV
- LPCN
- Stock Information
- Founded
- INUV N/A
- LPCN 1997
- Country
- INUV United States
- LPCN United States
- Employees
- INUV N/A
- LPCN N/A
- Industry
- INUV Advertising
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- INUV Consumer Discretionary
- LPCN Health Care
- Exchange
- INUV Nasdaq
- LPCN Nasdaq
- Market Cap
- INUV 35.6M
- LPCN 36.8M
- IPO Year
- INUV N/A
- LPCN N/A
- Fundamental
- Price
- INUV $0.24
- LPCN $5.46
- Analyst Decision
- INUV Strong Buy
- LPCN Strong Buy
- Analyst Count
- INUV 1
- LPCN 1
- Target Price
- INUV $1.00
- LPCN $10.00
- AVG Volume (30 Days)
- INUV 330.8K
- LPCN 23.4K
- Earning Date
- INUV 11-08-2024
- LPCN 11-06-2024
- Dividend Yield
- INUV N/A
- LPCN N/A
- EPS Growth
- INUV N/A
- LPCN N/A
- EPS
- INUV N/A
- LPCN N/A
- Revenue
- INUV $80,645,465.00
- LPCN $4,800,930.00
- Revenue This Year
- INUV $16.92
- LPCN N/A
- Revenue Next Year
- INUV $26.08
- LPCN N/A
- P/E Ratio
- INUV N/A
- LPCN N/A
- Revenue Growth
- INUV 28.33
- LPCN 8630.55
- 52 Week Low
- INUV $0.12
- LPCN $2.31
- 52 Week High
- INUV $0.57
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- INUV 45.56
- LPCN 61.75
- Support Level
- INUV $0.23
- LPCN $4.89
- Resistance Level
- INUV $0.27
- LPCN $5.85
- Average True Range (ATR)
- INUV 0.01
- LPCN 0.38
- MACD
- INUV 0.00
- LPCN 0.04
- Stochastic Oscillator
- INUV 22.16
- LPCN 64.83
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications, and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.